Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis

• Published in: Cells (Basel, Switzerland) Vol. 8; no. 4; p. 334
• Main Authors: Kritikou, Eva, Depuydt, Marie A.C., de Vries, Margreet R., Mulder, Kevin E., Govaert, Arthur M., Smit, Marrit D., van Duijn, Janine, Foks, Amanda C., Wezel, Anouk, Smeets, Harm J., Slütter, Bram, Quax, Paul H.A., Kuiper, Johan, Bot, Ilze
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 09.04.2019; MDPI
• Subjects: Arteriosclerosis; Atherosclerosis; Atherosclerosis - pathology; CD63 antigen; Cell activation; Cells, Cultured; Flow cytometry; Flow Cytometry - methods; Hemorrhage; Histamine; Histology; Human subjects; Humans; Immunoglobulin E; Immunoglobulin E - metabolism; Immunohistochemistry; Inflammation; mast cell; Mast cells; Mast Cells - metabolism; Mast Cells - pathology; plaque stability; Plaque, Atherosclerotic - pathology; Plaques; Population; Proto-Oncogene Proteins c-kit - metabolism; Receptors, IgE - metabolism; Surgery; Tetraspanin 30 - metabolism; Tryptase; Veins & arteries; United States > US; Netherlands; atherosclerosis; mast cell; flow cytometry; tryptase; plaque stability
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells8040334

The presence of mast cells in human atherosclerotic plaques has been associated with adverse cardiovascular events. Mast cell activation, through the classical antigen sensitized-IgE binding to their characteristic Fcε-receptor, causes the release of their cytoplasmic granules. These granules are filled with neutral proteases such as tryptase, but also with histamine and pro-inflammatory mediators. Mast cells accumulate in high numbers within human atherosclerotic tissue, particularly in the shoulder region of the plaque. These findings are largely based on immunohistochemistry, which does not allow for the extensive characterization of these mast cells and of the local mast cell activation mechanisms. In this study, we thus aimed to develop a new flow-cytometry based methodology in order to analyze mast cells in human atherosclerosis. We enzymatically digested 22 human plaque samples, collected after femoral and carotid endarterectomy surgery, after which we prepared a single cell suspension for flow cytometry. We were able to identify a specific mast cell population expressing both CD117 and the FcεR, and observed that most of the intraplaque mast cells were activated based on their CD63 protein expression. Furthermore, most of the activated mast cells had IgE fragments bound on their surface, while another fraction showed IgE-independent activation. In conclusion, we are able to distinguish a clear mast cell population in human atherosclerotic plaques, and this study establishes a strong relationship between the presence of IgE and the activation of mast cells in advanced atherosclerosis. Our data pave the way for potential therapeutic intervention through targeting IgE-mediated actions in human atherosclerosis.